The University of Texas Health Science Center at Houston (UTHSC-H), The University of Texas M.D. Anderson Cancer Center (UT MDACC), and the Memorial Hermann Hospital System wish to renew their Clinical and Translational Science Award (CTSA), which established the Center for Clinical and Translational Sciences (CCTS) in 2006. In the first cycle, the institutions created our CCTS, provided services to 835 investigators in 104 fields, trained KL2 scholars and TL1 trainees, and worked with the greater Houston and Brownsville communities to disseminate health care information and study the unique health issues in Brownsville's Hispanic border population. To further collaborative research in Texas, our CCTS founded the Texas CTSA Consortium and the Lowering the Barriers Program, which has established IRB reciprocity in the University of Texas System. Our CCTS's mission reads: The Center for Clinical and Translational Sciences provides research infrastructure, training and knowledge transfer to expedite the process of translating discovery to practice. We faciliate research and its dissemination for our investigators, our trainees and students, our patients, our local and state population, our Texas CTSA consortium collaborators, and the national CTSA consortium. To this end, we will focus on a thematic structure in the next cycle. Our themes are: 1) Advancing Translational Sciences by Advancing Personalized Therapy (T1 translation) by determing pathophysiology and developing targeted therapeutics and Advancing Community Engagement and dissemination and implementation research (T3/T4 translation);2) Advancing Clinical Sciences by accelerating and improving new modalities for the design and conduct of clinical research and by accelerating and improving outcomes of research (T2 translation);and 3) Advancing the Clinical and Translational Science Research Workforce (Post-graduate training. Graduate training and research staff training).
The goal of the Center for Clinical and Translational Sciences (CCTS), funded by a Clinical and Translational Science Award, is to move scientific and medical discoveries as fas as possible from the laboratory to the clinic and community, where they can improve the health of the American people. The CCTS trains researchers, provides research services, and works with its communities to learn their helath concerns and spread health care information.
|Ager, Casey R; Reilley, Matthew J; Nicholas, Courtney et al. (2017) Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity. Cancer Immunol Res 5:676-684|
|Chen, Jiyuan; Peters, Andrew; Papke, Christina L et al. (2017) Loss of Smooth Muscle ?-Actin Leads to NF-?B-Dependent Increased Sensitivity to Angiotensin II in Smooth Muscle Cells and Aortic Enlargement. Circ Res 120:1903-1915|
|Madankan, R; Stefan, W; Fahrenholtz, S J et al. (2017) Accelerated magnetic resonance thermometry in the presence of uncertainties. Phys Med Biol 62:214-245|
|Denny, George; Anadkat, Milan J (2017) The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study. J Am Acad Dermatol 76:54-59|
|Gao, Ruli; Kim, Charissa; Sei, Emi et al. (2017) Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer. Nat Commun 8:228|
|Hurton, Lenka V; Singh, Harjeet; Najjar, Amer M et al. (2016) Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells. Proc Natl Acad Sci U S A 113:E7788-E7797|
|Leung, Marco L; Wang, Yong; Kim, Charissa et al. (2016) Highly multiplexed targeted DNA sequencing from single nuclei. Nat Protoc 11:214-235|
|Morgado, Micaela; Sutton, Margie N; Simmons, Mary et al. (2016) Tumor necrosis factor-? and interferon-? stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NF?B. Oncotarget 7:14871-84|
|Whaley, Meagan Lee; Kadipasaoglu, Cihan Mehmet; Cox, Steven James et al. (2016) Modulation of Orthographic Decoding by Frontal Cortex. J Neurosci 36:1173-84|
|Wolfe, Adam R; Trenton, Nicholaus J; Debeb, Bisrat G et al. (2016) Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models. Oncotarget 7:82482-82492|
Showing the most recent 10 out of 105 publications